Genus PLC
09 January 2007
For Immediate Release 9 January 2007
GENUS plc
('Genus' or 'the Company')
Pre-Close Trading Update
Genus plc, the world's leading animal genetics company, is pleased to announce
that trading in the six month period ended 31 December 2006 has been in line
with the Board's expectations and, as already reported, the synergies and cost
savings achieved through the acquisition of Sygen International plc continue in
line with our enhanced targets of both quantum and timing.
The Board currently anticipates that market conditions will be broadly unchanged
for the second half of the financial year.
In progressing towards the announced move from AIM to the Official List, the
Company is preparing its historical accounts for the fifteen months to 30 June
2006 under International Financial Reporting Standards ('IFRS'). This work
is substantially complete and is in the process of being audited. The impact of
adopting IFRS on these accounts compared with the current accounting practice
('UK GAAP') is expected to be material in relation to the Agricultural Assets
Standard, IAS 41. As anticipated, the impact of this Standard will be to
increase the Company's net assets significantly as at 30 June 2006 by fair
valuing the Company's biological assets principally associated with the
Company's studs and nucleus herds. The impact of other differences is expected
to be immaterial. A transition document which will illustrate the reconciling
differences between UK GAAP and IFRS will be available on the Company's website
prior to the intended announcement on 13 March 2007 of the Interim Results for
the six months ended 31 December 2006.
After considering the complexity and additional cost of auditing the interim
results, required only for listing purposes, the Board has decided to conduct
the move to the Official List after the audited results for the year ending 30
June 2007 have been published.
In pursuit of the Board's strategy to improve liquidity in Genus shares and to
reduce the administration costs of servicing small shareholders, the Company
carried out a further voluntary share buyback programme in December 2006. As
a result, we are pleased to announce that a total of 836,469 shares (1.5% of
issued share capital) were placed with institutions under this programme.
For further information please contact:
Genus plc Tel: 01256 347 100
Richard Wood, Chief Executive
David Timmins, Finance Director
Buchanan Communications Tel: 020 7466 5000
Charles Ryland
Suzanne Brocks
Simon Potter
This information is provided by RNS
The company news service from the London Stock Exchange
EDF
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.